Mutation Spectrum of FLT3 and Significance of Non-Canonical FLT3 Mutations in Hematological Malignancy

Investigators profiled the spectrum of Fms-like tyrosine kinase 3 (FLT3) mutations in 869 consecutively newly diagnosed AML, myelodysplastic syndrome, and acute lymphoblastic leukemia patients.